Literature DB >> 25283276

Hepatic congestion leads to fibrosis: findings in a newly developed murine model.

Hisashi Hidaka1, Yasuko Iwakiri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25283276      PMCID： PMC4303496          DOI： 10.1002/hep.27550

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  15 in total

Review 1.  Thrombin generation and fibrin clot structure.

Authors:  Alisa S Wolberg
Journal:  Blood Rev       Date:  2007-01-08       Impact factor: 8.250

2.  Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.

Authors:  Erica Villa; Calogero Cammà; Marco Marietta; Monica Luongo; Rosina Critelli; Stefano Colopi; Cristina Tata; Ramona Zecchini; Stefano Gitto; Salvatore Petta; Barbara Lei; Veronica Bernabucci; Ranka Vukotic; Nicola De Maria; Filippo Schepis; Aimilia Karampatou; Cristian Caporali; Luisa Simoni; Mariagrazia Del Buono; Beatrice Zambotto; Elena Turola; Giovanni Fornaciari; Susanna Schianchi; Anna Ferrari; Dominique Valla
Journal:  Gastroenterology       Date:  2012-07-20       Impact factor: 22.682

Review 3.  Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Liver Int       Date:  2011-07-05       Impact factor: 5.828

4.  eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro.

Authors:  K N Kader; R Akella; N P Ziats; L A Lakey; H Harasaki; J P Ranieri; R V Bellamkonda
Journal:  Tissue Eng       Date:  2000-06

Review 5.  Tissue factor pathway inhibitor: structure, biology and involvement in disease.

Authors:  Bashir A Lwaleed; Paul S Bass
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

6.  Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.

Authors:  Wataru Abe; Kenichi Ikejima; Tie Lang; Kyoko Okumura; Nobuyuki Enomoto; Tsuneo Kitamura; Yoshiyuki Takei; Nobuhiro Sato
Journal:  J Hepatol       Date:  2006-10-25       Impact factor: 25.083

7.  Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study.

Authors:  T J Kendall; B Stedman; N Hacking; M Haw; J J Vettukattill; A P Salmon; R Cope; N Sheron; H Millward-Sadler; G R Veldtman; J P Iredale
Journal:  J Clin Pathol       Date:  2007-10-26       Impact factor: 3.411

8.  Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies.

Authors:  Q M Anstee; R D Goldin; M Wright; A Martinelli; R Cox; M R Thursz
Journal:  J Thromb Haemost       Date:  2008-05-14       Impact factor: 5.824

Review 9.  Hepatic venous outflow obstruction: three similar syndromes.

Authors:  Ulas-Darda Bayraktar; Soley Seren; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 10.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

Authors:  Yasuko Iwakiri; Vijay Shah; Don C Rockey
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083
View more
  2 in total

Review 1.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 2.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.